Australia ranks among the largest healthcare markets worldwide, and the pharma industry invests more than $1 billion in R&D in the country annually, despite its relatively small population. Australia’s national public health program covers a high percentage of the cost of a variety of medicines, medical services and hospital care.
Advertising and communicating directly to the public about prescription-only medicines or experimental drugs is prohibited, except for government-controlled public health campaigns. The Therapeutic Goods Administration (TGA) is Australia’s regulatory authority for therapeutic goods, and the promotion of medicines is self-regulated by the pharmaceutical industry’s Medicines Australia Code of Conduct.
Sign up to get the guides
Select the guides you wish to download